PERNIX THERAPEUTICS HLDGS IN - COM NEW (PTXTQ)

CUSIP: 71426V306

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / COM NEW
Total 13F shares
2,077,629
Share change
+48,163
Total reported value
$5,045,430
Put/Call ratio
183%
Price per share
$2.43
Number of holders
16
Value change
+$119,937
Number of buys
10
Number of sells
7

Quarterly Holders Quick Answers

What is CUSIP 71426V306?
CUSIP 71426V306 identifies PTXTQ - PERNIX THERAPEUTICS HLDGS IN - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PERNIX THERAPEUTICS HLDGS IN - COM NEW (PTXTQ) as of Q2 2018

As of 30 Jun 2018, PERNIX THERAPEUTICS HLDGS IN - COM NEW (PTXTQ) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,077,629 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BlackRock Inc., Aisling Capital LLC, JACOBS LEVY EQUITY MANAGEMENT, INC, BANK OF MONTREAL /CAN/, GEODE CAPITAL MANAGEMENT, LLC, Cetera Investment Advisers, NORTHERN TRUST CORP, and GOLDMAN SACHS GROUP INC. This page lists 16 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.